AAAAAA

   
Results: 1-10 |
Results: 10
ARTERIAL OCCLUSIONS AS A PRESENTING FEATURE OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: ROLSTON DDK RUBIN S TOPOLSKY D STYLER M CRILLEY P
Citation: Ddk. Rolston et al., ARTERIAL OCCLUSIONS AS A PRESENTING FEATURE OF ACUTE PROMYELOCYTIC LEUKEMIA, American journal of clinical oncology, 21(5), 1998, pp. 436-437
LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF
Authors: CRILLEY P TOPOLSKY D MARKS DI STYLER M SABOL P BRODSKY I
Citation: P. Crilley et al., LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF, Experimental hematology, 24(9), 1996, pp. 633-633
SPLENECTOMY FOR NON-HODGKINS-LYMPHOMA
Authors: BRODSKY J ABCAR A STYLER M
Citation: J. Brodsky et al., SPLENECTOMY FOR NON-HODGKINS-LYMPHOMA, American journal of clinical oncology, 19(6), 1996, pp. 558-561
LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE INUNRELATED MARROW TRANSPLANT RECIPIENTS
Authors: STYLER M CRILLEY P TOPOLSKY D RUBIN S SABOL P KING R BRODSKY I
Citation: M. Styler et al., LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE INUNRELATED MARROW TRANSPLANT RECIPIENTS, Blood, 88(10), 1996, pp. 3765-3765
THE USE OF G-CSF AFTER PERIPHERAL STEM-CELL (PBSC) TRANSPLANT - BEGINNING AT DIFFERENT INTERVALS POST INFUSION
Authors: TOPOLSKY D KING R MULLANEY R STYLER M CRILLEY P SABOL P BRODSKY L
Citation: D. Topolsky et al., THE USE OF G-CSF AFTER PERIPHERAL STEM-CELL (PBSC) TRANSPLANT - BEGINNING AT DIFFERENT INTERVALS POST INFUSION, Blood, 88(10), 1996, pp. 3766-3766
EFFECT OF INFLUENZA VACCINE POST-ALLOGENEIC BONE-MARROW TRANSPLANT
Authors: TOPOLSKY D BLUMBERG E CRILLEY P STYLER M HAYDEN F CHURCHILL K MORRIS M BRODSKY I
Citation: D. Topolsky et al., EFFECT OF INFLUENZA VACCINE POST-ALLOGENEIC BONE-MARROW TRANSPLANT, Blood, 86(10), 1995, pp. 860-860
OCULAR GRAFT-VERSUS-HOST DISEASE
Authors: HEFFLER KF GROSSMAN H MARKS D TOPOLSKY D STYLER M MOUL J CRILLEY P BRODSKY I
Citation: Kf. Heffler et al., OCULAR GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 3784-3784
BUCY3 CONDITIONING FOR UNRELATED DONOR TRANSPLANTS FOR HEMATOLOGIC MALIGNANCIES
Authors: MARKS D CRILLEY P STYLER M TOPOLSKY D MANALO Y BRODSKY I
Citation: D. Marks et al., BUCY3 CONDITIONING FOR UNRELATED DONOR TRANSPLANTS FOR HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000336-10000336
COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES
Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I
Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54
INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2)
Authors: STYLER M BIGGS JC TOPOLSKY D ATKINSON K BULOVA S DOWNS K KOZUCH P BRODSKY I CRILLEY P
Citation: M. Styler et al., INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2), Blood, 82(10), 1993, pp. 10000642-10000642
Risultati: 1-10 |